Lupin Pharmaceuticals Inc. recalls Amlodipine Besylate Tablets, USP 10 mg, 1000-count bottles, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland…
Subpotent Drug: Out-of-Specification test results observed in assay test at 21-month long term stability study.
Read the official notice →- Date
- 2023-07-19
- Country
- United States
- Brand
- Lupin Pharmaceuticals
- Product
- Amlodipine Besylate Tablets, USP 10 mg, 1000-count bottles, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland…
- Classification
- Class III
- Units
- Product was distributed directly to three distributors in TN and NJ. Product…
- Category
- Drugs & medical
- Source
- FDA · Drug
Copied automatically from the US Food and Drug Administration. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer
What to do
- Check the product name, strength and lot number against the official notice.
- Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
- Ask the pharmacy or supplier about a replacement or refund.
General guidance from Recall Atlas. The official notice from the US Food and Drug Administration has the exact models, batch codes and remedy, and it takes priority.
More Lupin Pharmaceuticals recalls
- 2024-01-17
USLupin Pharmaceuticals Inc. recalls Desloratadine Tablets USP 5mg a) 100 count (NDC 68180-153-01) and b) 500 count (NDC 68180-153-02) bottles, Rx Only, Manufactured for:…
CGMP Deviations: N-Nitroso Desloratadine impurity result exceeded the acceptable intake limit.
- 2023-12-20
- US
Lupin Pharmaceuticals Inc. recalls Penicillamine Tablets USP 250 mg, 100-count bottle, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, MD 21202…
Failed Dissolution Specifications
FDA · DrugLupin Pharmaceuticals Inc.Product was distributed to 3 wholesale/distributor accounts.Official notice → - 2023-08-09
- US
Lupin Pharmaceuticals Inc. recalls Tydemy (drospirenone, ethinyl estradiol and levomefolate calcium tablets, 3 mg/0.03 mg/0.451 mg and levomefolate calcium tablets 0.451…
Failed Stability Specification and Failed Impurities/Degradation Specifications: out of specification for inactive content ascorbic acid and MTHFRC-7impurity test
- 2023-02-01
- US
Lupin Pharmaceuticals Inc. recalls Clobetasol propionate Cream USP, 0.05%, 45 g tube, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202,…
Subpotent Drug: Low assay result observed during long-term stability testing.
- 2023-01-18
- US
Lupin Pharmaceuticals Inc. recalls Rifampin Capsules USP, 300 mg, 30-count bottle; Rx Only, Manufactured for: Lupin Pharmaceuticals Baltimore, Maryland 21202,…
Failed Impurities/Degradation Specifications: Failure observed in related substance testing during long term stability study.
- 2022-12-28
- US
Lupin Pharmaceuticals Inc. recalls Quinapril Tablets USP, 20 mg (90 pack), Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202, by: Lupin…
CGMP Deviations: Detection of N-Nitroso-quinapril impurity above the acceptable daily intake limit.
FDA · DrugLupin Pharmaceuticals Inc.Product was distributed by major distribution chains nationwide.Official notice →
Other drugs & medical recalls in the United States
- 2023-07-19
- US
SUN PHARMACEUTICAL INDUSTRIES INC recalls Tiagabine Hydrochloride Tablets, 2 mg, 30-count bottle, Distributed by Sun Pharmaceutical Industries. Inc. Cranbury NJ 08512,…
Failed Impurities: Out of Specification (OOS) result observed during Related Substances testing
- US
Teva Pharmaceuticals USA Inc recalls Sunitinib Malate Capsules, 12.5 mg, 28-count bottles, Rx only, Manufactured By: Teva Pharmaceuticals USA, Inc., Parsippany, NJ…
Failed Moisture Limits: Water (moisture) content above the approved product specifications.
FDA · DrugTeva Pharmaceuticals USA IncProduct was distributed to 3 wholesalers/distributors who further distributed…Official notice → - US
L. Perrigo Company recalls allergy relief, Fexofenadine Hydrochloride Tablets, 180 mg, packaged in a)15-count cartons (NDC 11673-617-22), b)30-count cartons (NDC…
Failed Impurities/Degradation Specifications
- US
K.C. Pharmaceuticals, Inc recalls Dry Eye Relief Lubricant Eye Drops, (Glycerin 0.2%, Hypromellose 0.2 %, Polyethylene glycol 400 1%), 0.5 FL OZ (15mL) bottle, packaged…
CGMP Deviations: good manufacturing deficiencies related to a lack of documentation of the fill line.
- US
- 2023-07-12
- US
Philips Respironics, Inc. recalls Trilogy Evo, Evo Clinical Korean (1137823) and Evo Caregiver Korean (1137853) Instructions for Use
There are errors present in the Korean Instructions For Use where the word "invasive," was incorrectly translated to "noninvasive".